维普中文期刊产品整合服务
289篇 您的检索式:作者名="Rustgis"
    题名 作者 年代 出处 被引量
1EMT and Dissemination Precede Pancreatic Tumor Formation显示文摘Andrew D. Rhim Emily T. Mirek Nicole M. Aiello Anirban Maitra Jennifer M. Bailey Florencia McAllister Maximilian Reichert Gregory L. Beatty Anil K. Rustgi Robert H. Vonderheide Steven D. Leach Ben Z. Stanger 2012Cell2012,,1:13
2Acute kidney injury and hepatorenal syndrome in cirrhosis显示文摘Acute kidney injury(AKI)in cirrhosis,including hepatorenal syndrome(HRS),is a common and serious complication in cirrhotic patients,leading to significant morbidity and mortality.AKI is separated into two categories,non-HRS AKI and HRS-AKI.The most recent definition and diagnostic criteria of AKI in cirrhosis and HRS have helped diagnose and prognosticate the disease.The pathophysiology behind non-HRS-AKI and HRS is more complicated than once theorized and involves more processes than just splanchnic vasodilation.The common biomarkers clinicians use to assess kidney injury have significant limitations in cirrhosis patients;novel biomarkers being studied have shown promise but require further studies in clinical settings and animal models.The overall management of non-HRS AKI and HRS-AKI requires a systematic approach.Although pharmacological treatments have shown mortality benefit,the ideal HRS treatment option is liver transplantation with or without simultaneous kidney transplantation.Further research is required to optimize pharmacologic and nonpharmacologic approaches to treatment.This article reviews the current guidelines and recommendations of AKI in cirrhosis.Kapil Gupta Abhishek Bhurwal Cindy Law Scott Ventre Carlos D Minacapelli Savan Kabaria You Li Christopher Tait Carolyn Catalano Vinod K Rustgi 2021World Journal of Gastroenterology2021,27,26:5
3Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial显示文摘Michael P Manns John G McHutchison Stuart C Gordon Vinod K Rustgi Mitchell Shiffman Robert Reindollar Zachary D Goodman Kenneth Koury Mei-Hsiu Ling Janice K Albrecht 2001The Lancet2001,,9286:4
4Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial显示文摘Michael P Manns John G McHutchison Stuart C Gordon Vinod K Rustgi Mitchell Shiffman Robert Reindollar Zachary D Goodman Kenneth Koury Mei-Hsiu Ling Janice K Albrecht 2001The Lancet . 2001 (9286)2001,,9286:4
5Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial显示文摘Michael P Manns John G McHutchison Stuart C Gordon Vinod K Rustgi Mitchell Shiffman Robert Reindollar Zachary D Goodman Kenneth Koury Mei-Hsiu Ling Janice K Albrecht 20012001 (9286)2001,,9286:4
6Colon Cancer: An Update and Future Directions显示文摘Vincent W. Yang James Lewis Timothy C. Wang Anil K. Rustgi 2010Gastroenterology2010,,6:2
7Linkage disequilibrium and association studies in higher plants: Present status and future prospects显示文摘Pushpendra K. Gupta Sachin Rustgi Pawan L. Kulwal 2005Plant Molecular Biology2005,,4:2
8Pancreatic ductal cells in development, regeneration, and neoplasia显示文摘Reichert Maximilian Rustgi Anil K 2011Journal of Clinical Investigation2011,,12:2
9The keratinocyte-specific Epstein-Barr virus ED-L2 promoter is regulated by phorbol 12-myristate 13-acetate through two cis-regulatory elements containing E-box and Kruppel-like factor motifs 显示文摘Jenkins TD Nakagawa H Rustgi AK 1997Biol Chem1997,272,24:1
10Esophageal carcinoma显示文摘Rustgi AK El-Serag HB 2014N Engl J Med2014,371,26:1
11Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C显示文摘Nelson DR Rustgi V Balan V 2009Clin Gastroenterol Hepatol2009,7,2:1
12A CACCC box-like cis-regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamouse epithelia显示文摘Nakagawa H Inomoto T Rustgi AK 1997J Biol C hem1997,272,16:1
13Hereditary gastrointestinal polyposis and nonpolyposis syndromes显示文摘Rustgi AK 1994N Engl J Med1994,331,25:1
14Pancreatic ductal cells in development,regeneration,and neoplasia显示文摘Reichert M Rustgi AK 0,,12:1
15Interferon alfa2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C显示文摘McHutchison JG Gordon SC Schiff ER Shiffrnan ML Lee WM Rustgi VK Goodman ZD Ling MH Cort S Albrecht JK 0,,:1
16Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes显示文摘Raghu Kadaba Hanna Birke Jun Wang Steven Hooper Claudia D Andl Francesco Di Maggio Erdinc Soylu Mohammed Ghallab Daniel Bor Fieke EM Froeling Satyajit Bhattacharya Anil K Rustgi Erik Sahai Claude Chelala Peter Sasieni Hemant M Kocher 2013J. Pathol2013,,1:1
17Transferable EST-SSR markers for the study of polymorphism and genetic diversity in bread wheat 显示文摘Gupta P K Rustgi S Sharma S 2003Molecular Genetics and Genomics2003,270,:1
18The role of the miR-200 family in epithelial-mesenchymal transition显示文摘Mongroo PS Rustgi AK 2010Cancer Biol Ther2010,10,3:1
19CD44 isoform expression in primary and metastaic pancreastic adenocatcinoma显示文摘 Rustgi A K 1995Cancer Res1995,55,9:1
20Biodegradation of Maleated Linear Low-Density Polyethylene and Starch Blends显示文摘Chandra R Rustgi R 1997Polym Degra Stab1997,56,:1
返回顶部 每页显示:
共15页 首页 上一页 第1页 下一页 末页 /15 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费